Journal Reference : Javier Bracchiglione, Nicols Meza, Juan VA Franco, Camila Micaela Escobar Liquitay, Victoria Novik A, Miranda Ocara Vargas, Gabriel Lazcano, Daniel Poloni, Francisca Rinaldi Langlotz, Marta Roqu-Figuls, Sergio R Munoz, Eva Madrid
If you are on the maximum dose range (8 to 12mg), your risk is higher than someone on microdoses
But heres where the reality diverges from the hype
As much of a miracle weight-loss drug as the media has made it out to be, it is intended to be used in adjunct to lifestyle interventions to be successful
The SELECT study on Novos Wegovy showed a c20% reduction in the risk of heart disease (heart attack, stroke or cardiovascular death) when taken for 5 years, compared to those who did not
9 The main treatment for these patients are SGLT2 inhibitors which can improve HFpEF outcomes and slow down the progression of CKD